SynthesisClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2024
Global Prevalence of Fecal Incontinence in Community-Dwelling Adults: A Systematic Review and Meta-analysis.
Synthesis in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 7 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Fecal incontinence after prostate cancer irradiation: a systematic literature review.Prostate cancer and prostatic diseases · 2026Pooled it
- Association Between Sexual Violence and Reported Anorectal Symptoms Among Adults: A Systematic Review.International urogynecology journal · 2026Pooled it
- Gastroenterological disorders and hepatic disease in adults with cerebral palsy: A systematic review.Developmental medicine and child neurology · 2026Pooled it
- Effectiveness of group-based art interventions for late-life depression: a systematic review and meta-analysis of randomized controlled trials.BMC medicine · 2026Pooled it
- Prevalence of fecal incontinence after childbirth in Turkey: systematic review and meta-analysis.Irish journal of medical science · 2025Pooled it
- Skin cleansers and leave-on product interventions for preventing incontinence-associated dermatitis in adults.The Cochrane database of systematic reviews · 2025Pooled it
- Is magnetic anal sphincter augmentation still an option in fecal incontinence treatment: a systematic review and meta-analysis.Langenbeck's archives of surgery · 2024Pooled it
- Clinical Trial: Effectiveness and Safety of a Novel Anal Insert Device for Treatment of Faecal Incontinence.Alimentary pharmacology & therapeutics · 2026Trial
- Measuring health-related quality of life and well-being in adults with fecal incontinence: a comparative psychometric evaluation.Health and quality of life outcomes · 2026Trial
- Controlling Fecal Incontinence With a Novel Anal Device: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Fecal and urinary incontinence in older men with hip fracture: a geriatric syndrome with prognostic significance.European geriatric medicine · 2026Article
- Editorial: A New Insert Device for Faecal Incontinence-To Use or Not to Use?Alimentary pharmacology & therapeutics · 2026Article
- Biofeedback Therapy and Pelvic Floor Physical Therapy in the Treatment of Constipation and Fecal Incontinence Are Very Different in Real-World Practice.Neurogastroenterology and motility · 2026Article
- The Utility of the Functional Sphincter Area: A Novel Functional Lumen Imaging Probe Parameter for the Assessment of Anal Sphincter Structure and Function in Fecal Incontinence.Journal of neurogastroenterology and motility · 2026Article
- Transanal irrigation in clinical practice: a scoping review.International journal of colorectal disease · 2026Article
- Sensation of Incomplete Evacuation in Patients With Fecal Incontinence: A Cross-Sectional Study of a Tertiary Referral Cohort.Neurogastroenterology and motility · 2026Article
- Female pelvic floor protection-Where do we have to go?Acta obstetricia et gynecologica Scandinavica · 2026Review
- Preliminary Content Validation and Translation of the Modified Initial Measurement of Patient-Reported Pelvic Floor Complaints Tool Short Form in Kannada.International urogynecology journal · 2026Article
- Associations between five anthropometric indices and fecal incontinence: A cross-sectional study based on the 2005 to 2010 NHANES data.Medicine · 2026Article
- A Digital Therapeutic Pelvic Health System Improves Fecal Incontinence Symptoms in a Real-World Patient Cohort.Diseases of the colon and rectum · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
Abstract
BACKGROUND &
aimsFecal incontinence (FI) can considerably impair quality of life. Through a systematic review and meta-analysis, we sought to determine the global prevalence and geographic distribution of FI and to characterize its relationship with sex and age.
methodsWe searched PubMed, Web of Science, and Cochrane Library databases to identify population-based surveys of the prevalence of FI.
resultsOf the 5175 articles identified, the final analysis included 80 studies; the median response rate was 66% (interquartile range [IQR], 54%-74%). Among 548,316 individuals, the pooled global prevalence of FI was 8.0% (95% confidence interval [CI], 6.8%-9.2%); by Rome criteria, it was 5.4% (95% CI, 3.1%-7.7%). FI prevalence was greater for persons aged 60 years and older (9.3%; 95% CI, 6.6%-12.0%) compared with younger persons (4.9%; 95% CI, 2.9%-6.9%) (odds ratio [OR], 1.75; 95% CI, 1.39-2.20), and it was more prevalent among women (9.1%; 95% CI, 7.6%-10.6%) than men (7.4%; 95% CI, 6.0%-8.8%]) (OR, 1.17; 95% CI, 1.06-1.28). The prevalence was highest in Australia and Oceania, followed by North America, Asia, and Europe, but prevalence could not be estimated in Africa and the Middle East. The risk of bias was low, moderate, and high for 19 (24%), 46 (57%), and 15 (19%) studies, respectively. Exclusion of studies with high risk of bias did not affect the prevalence of FI or heterogeneity. In the meta-regression, the high study heterogeneity (I
conclusionsApproximately 1 in 12 adults worldwide have FI. The prevalence is greater among women and older people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.